Back to top

Akebia (AKBA) Launches VOCAL Trial to Assess Vafseo Benefits

Akebia (AKBA) Launches VOCAL Trial to Assess Vafseo Benefits

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Akebia Therapeutics, Inc. (AKBA)